Cargando…

Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value

BACKGROUND: Systematic analysis of cancer gene-expression patterns using high-throughput transcriptional profiling technologies has led to the discovery and publication of hundreds of gene-expression signatures. However, few public signature values have been cross-validated over multiple studies for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehmann, Brian David, Ding, Yan, Viox, Daniel Joseph, Jiang, Ming, Zheng, Yi, Liao, Wang, Chen, Xi, Xiang, Wei, Yi, Yajun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404582/ https://www.ncbi.nlm.nih.gov/pubmed/25886164 http://dx.doi.org/10.1186/s12885-015-1102-7

Ejemplares similares

Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma
por: Kancherla, Venkatesh, et al.
Publicado: (2018)

Common activities and predictive gene signature identified for genetic hypomorphs of TP53
por: Leung, Jessica C., et al.
Publicado: (2023)

TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
por: Akahane, Tomoko, et al.
Publicado: (2022)

Expression signatures of TP53 mutations in serous ovarian cancers
por: Bernardini, Marcus Q, et al.
Publicado: (2010)

Unique volatolomic signatures of TP53 and KRAS in lung cells
por: Davies, M P A, et al.
Publicado: (2014)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

A transcriptomic signature for prostate cancer relapse prediction identified from the differentially expressed genes between TP53 mutant and wild-type tumors
por: Zhang, Wensheng, et al.
Publicado: (2022)

Integrative Analysis Reveals a Nine TP53 Pathway-Related lncRNA Prognostic Signature in Endometrial Cancer
por: Wang, Ying, et al.
Publicado: (2022)

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
por: Guo, Chunguang, et al.
Publicado: (2022)

Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial Carcinoma
por: Chen, Ying, et al.
Publicado: (2022)

The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma
por: Omura, Go, et al.
Publicado: (2017)

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
por: Wu, Xiangkun, et al.
Publicado: (2020)

TP53 Signature Can Predict Pathological Response From Neoadjuvant Chemotherapy and Is a Prognostic Factor in Patients With Residual Disease
por: Takahashi, Shin, et al.
Publicado: (2023)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients
por: Cho, Sung-Yup, et al.
Publicado: (2017)

Decentralized Learning Framework of Meta-Survival Analysis for Developing Robust Prognostic Signatures
por: Cui, Yi, et al.
Publicado: (2017)

Novel Model for Comprehensive Assessment of Robust Prognostic Gene Signature in Ovarian Cancer Across Different Independent Datasets
por: Bing, Zhitong, et al.
Publicado: (2019)

Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival()
por: Mullany, Lisa K., et al.
Publicado: (2015)

The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer
por: Lin, Jiaying, et al.
Publicado: (2017)

Molecular profiling identifies distinct subtypes across TP53 mutant tumors
por: Chen, Xin, et al.
Publicado: (2022)

Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer
por: Zhang, Lanxin, et al.
Publicado: (2022)

The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies
por: Yang, Chang, et al.
Publicado: (2021)

Molecular and clinical features of the TP53 signature gene expression profile in early-stage breast cancer
por: Yamaguchi, Shigeo, et al.
Publicado: (2018)

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
por: Lyu, Haoyu, et al.
Publicado: (2019)

TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer
por: Zhang, Feng, et al.
Publicado: (2021)

Alcohol dehydrogenase 4 is a TP53-associated gene signature for the prediction of prognosis in hepatocellular carcinoma
por: Zhang, Yuan, et al.
Publicado: (2022)

TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study
por: Tao, Yuting, et al.
Publicado: (2022)

Signatures and prognostic values of related immune targets in tongue cancer
por: Lv, Xiaofei, et al.
Publicado: (2023)

Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
por: Na, Bing, et al.
Publicado: (2019)

Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer
por: Caponio, Vito Carlo Alberto, et al.
Publicado: (2020)

Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues
por: Sun, Rongwei, et al.
Publicado: (2014)

Gene signatures with predictive and prognostic survival values in human osteosarcoma
por: Qiu, Zhongpeng, et al.
Publicado: (2021)

Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma
por: Lei, Shizhen, et al.
Publicado: (2022)

Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross‐sectional study (2016‐2017)
por: Alvarez, Christian S., et al.
Publicado: (2020)

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
por: Abrams, Stephen L., et al.
Publicado: (2022)

A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma
por: Xu, Feng, et al.
Publicado: (2020)

KRAS/LKB1 and KRAS/TP53 co-mutations create divergent immune signatures in lung adenocarcinomas
por: Gu, Meichen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pml1imbl6v271dfmj11apuhbss